Metabolic syndrome: an appraisal of the pro-inflammatory and procoagulant status

被引:103
作者
Devaraj, S
Rosenson, RS
Jialal, I
机构
[1] Univ Calif Davis, Med Ctr, Lab Atherosclerosis & Metab Res, Sacramento, CA 95817 USA
[2] Northwestern Univ, Feinberg Sch Med, Dept Med, Div Cardiol,Prevent Cardiol Ctr, Chicago, IL 60611 USA
[3] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Div Cardiol,Prevent Cardiol Ctr, Chicago, IL 60611 USA
关键词
D O I
10.1016/j.ecl.2004.03.008
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Inflammation and hypercoagulability predispose to atherothrombosis and seem to be important features of the metabolic syndrome. The most convincing evidence is the association with increased levels of C-reactive protein. The hemostatic abnormality that has been most consistently associated with insulin resistance is an elevated plasminogen activator inhibitor-1 level. In contrast, markers of hypercoagulability have been associated inconsistently with hyperinsulinemia and glucose intolerance. Fibrinogen clusters with inflammatory factors, which suggests involvement of adipose tissue-generated inflammatory cytokines. Elevated von Willebrand's factor and factor VIII levels aggregate with indicators of endothelial injury, whereas vitamin K-dependent coagulation proteins correlate with triglyceride levels.
引用
收藏
页码:431 / +
页数:24
相关论文
共 127 条
  • [1] Adipokines, inflammation, and the endothelium in diabetes
    Waleed Aldhahi
    Osama Hamdy
    [J]. Current Diabetes Reports, 2003, 3 (4) : 293 - 298
  • [2] Relationship of metabolic syndrome and fibrinolytic dysfunction to cardiovascular disease
    Anand, SS
    Yi, QL
    Gerstein, H
    Lonn, E
    Jacobs, R
    Vuksan, V
    Teo, K
    Davis, B
    Montague, P
    Yusuf, S
    [J]. CIRCULATION, 2003, 108 (04) : 420 - 425
  • [3] The adipocyte in insulin resistance: key molecules and the impact of the thiazolidinediones
    Arner, P
    [J]. TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2003, 14 (03) : 137 - 145
  • [4] The relation of markers of inflammation to the development of glucose disorders in the elderly - The cardiovascular health study
    Barzilay, JI
    Abraham, L
    Heckbert, SR
    Cushman, M
    Kuller, LH
    Resnick, HE
    Tracy, RP
    [J]. DIABETES, 2001, 50 (10) : 2384 - 2389
  • [5] THE ACUTE-PHASE RESPONSE
    BAUMANN, H
    GAULDIE, J
    [J]. IMMUNOLOGY TODAY, 1994, 15 (02): : 74 - 80
  • [6] Role of cytokines in the regulation of plasminogen activator inhibitor-1 expression and secretion in newly differentiated subcutaneous human adipocytes
    Birgel, M
    Gottschling-Zeller, H
    Röhrig, K
    Hauner, H
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (06) : 1682 - 1687
  • [7] Impaired glucose tolerance, Type II diabetes mellitus and carotid atherosclerosis: prospective results from the Bruneck Study
    Bonora, E
    Kiechl, S
    Oberhollenzer, F
    Egger, G
    Bonadonna, RC
    Muggeo, M
    Willeit, J
    [J]. DIABETOLOGIA, 2000, 43 (02) : 156 - 164
  • [8] Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells
    Calabró, P
    Willerson, JT
    Yeh, ETH
    [J]. CIRCULATION, 2003, 108 (16) : 1930 - 1932
  • [9] ACUTE-PHASE RESPONSE OF HUMAN HEPATOCYTES - REGULATION OF ACUTE-PHASE PROTEIN-SYNTHESIS BY INTERLEUKIN-6
    CASTELL, JV
    GOMEZLECHON, MJ
    DAVID, M
    FABRA, R
    TRULLENQUE, R
    HEINRICH, PC
    [J]. HEPATOLOGY, 1990, 12 (05) : 1179 - 1186
  • [10] C-reactive protein, insulin resistance, central obesity, and coronary heart disease risk in Indian Asians from the United Kingdom compared with European whites
    Chambers, JC
    Eda, S
    Bassett, P
    Karim, Y
    Thompson, SG
    Gallimore, JR
    Pepys, MB
    Kooner, JS
    [J]. CIRCULATION, 2001, 104 (02) : 145 - 150